MDA Space's quarterly results offer a direct read on the commercial and government space economy, where the company competes as a prime contractor for satellite systems, space robotics, and Earth observation. Its growth has been anchored in large constellation programs such as Telesat Lightspeed and Globalstar's next-generation low Earth orbit (LEO) network, along with the Canadarm3 robotics program. The third quarter is especially important because it shows whether those contracts are converting into revenue at the pace investors expect, and whether margins can hold while the company scales its Montreal manufacturing capacity. With a shrinking backlog and a large future pipeline, this report also signaled how management views demand heading into 2027. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, MDA Space reported revenue of $498.1 million, up from $409.8 million in the same period last year. Satellite Systems drove the increase, rising to $358.3 million from $283.5 million, while Robotics & Space Operations edged up to $79.9 million from $78.3 million and Geointelligence advanced to $59.9 million from $48.0 million.
Net income was $30.9 million, compared with $27.0 million a year earlier. Diluted EPS came in at $0.19 versus $0.21 in the prior-year quarter, reflecting a higher share count, while adjusted diluted EPS held flat at $0.37. The company also raised its full-year 2026 revenue outlook to between $1.90 billion and $1.95 billion, up from a prior range of $1.8 billion to $1.9 billion. Order backlog stood at $3.95 billion at quarter-end, down from $4.39 billion a year earlier.
Investor reaction to MDA Space's results was shaped by the balance between strong top-line momentum and the pace at which backlog is being drawn down. The raised full-year revenue guidance provided a positive signal on demand visibility, but the declining backlog and the relatively modest year-over-year gain in adjusted EPS left room for debate about how quickly future growth will materialize. Sentiment around space and defense contractors remains generally constructive, supported by sustained government and commercial investment, yet investors continue to watch working capital swings and program timing, which can create uneven quarterly cash-flow results even as revenue trends higher.
Looking ahead, investors will focus on whether MDA Space can sustain its growth trajectory as large satellite programs move through later engineering and manufacturing phases. The raised 2026 revenue guidance suggests management sees solid demand through year-end, but the company will need to replenish its backlog with new contract awards to support growth into 2027.
Key factors to monitor include the timing of deliveries on the Globalstar and Telesat Lightspeed programs, progress on the Canadarm3 development phases, and the ramp-up of the expanded Montreal manufacturing facility. Margin trends will also be in focus as the company scales production capacity and invests in research and development, while working capital fluctuations may continue to affect quarterly cash flow.
Industry-wide, sustained spending on satellite communications, national security, and space exploration remains a supportive backdrop. However, cost pressures, supply-chain timing, and the pace of contract signings will determine whether the company can convert its pipeline into durable revenue growth without sacrificing profitability. From what I see, these elements will shape performance in the quarters ahead.
In my own analysis process, I’ve found Tickeron’s AI Screener to be a practical resource for quickly filtering stocks by sector, technical patterns, and fundamentals. It helps surface comparable names in aerospace and space tech, allowing for more efficient cross-checks on metrics like revenue growth and backlog trends. This kind of tool adds a layer of data-driven perspective when evaluating names like MDA Space alongside peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MDA saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned negative. In 48 of the 68 cases, the stock moved further down in the following days. The odds of a decline are at 71%.
The Moving Average Convergence Divergence Histogram (MACD) for MDA turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 25 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Aroon Indicator for MDA entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +3.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDA advanced for three days, in 181 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
MDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.249) is normal, around the industry mean (5.045). P/E Ratio (32.383) is within average values for comparable stocks, (17.993). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (2.913) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. MDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense